Analyst firms · TD Cowen · ILMN
TD Cowen ILMN price target and rating history
Illumina Inc. (ILMN) · Health Care
TD Cowen rates Illumina Inc. (ILMN) Hold with a $140 price target, as of its latest action on Feb 7, 2025. It has published 4 rating actions on ILMN since October 2021, including 1 upgrade and 2 downgrades. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
- Current rating
- Hold
- Price target
- $140
- Median target, all firms
- $185
- Actions on ILMN
- 4
TD Cowen price target on ILMN
Every TD Cowen rating on ILMN
- Feb 7, 2025
- Aug 14, 2024
- Jan 4, 2024
- Oct 15, 2021
How other firms rate ILMN
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stephens | Equal-Weight | $275 | Oct 23, 2026 |
| UBS | Buy | $260 | Sep 9, 2026 |
| Bernstein | Mkt Perform | $185 | Jun 26, 2026 |
| RBC Capital Markets | Outperform | $170 | May 15, 2026 |
| Daiwa | Outperform | $155 | May 14, 2026 |
Questions about TD Cowen and ILMN
- What is TD Cowen's price target for ILMN?
- TD Cowen's latest stated price target for Illumina Inc. (ILMN) is $140, from its action on Feb 7, 2025.
- What is TD Cowen's rating on ILMN?
- TD Cowen rates ILMN Hold, a neutral rating, as of Feb 7, 2025.
- When did TD Cowen last change its view on ILMN?
- On Feb 7, 2025, TD Cowen downgrades to Hold from Buy, price target $177 to $140.
- How does TD Cowen's ILMN target compare with other analysts?
- Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.
More ILMN rating histories
All TD Cowen ratingsILMN news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.